Ebola Virus Genome Plasticity as a Marker of Its Passaging History: A Comparison of In Vitro Passaging to Non-Human Primate Infection
Abstract
To identify polymorphic sites that could be used as biomarkers of Ebola virus passage history, we repeatedly amplified Ebola virus (Kikwit variant) in vitro and in vivo and performed deep sequencing analysis of the complete genomes of the viral subpopulations. We then determined the sites undergoing selection during passage in Vero E6 cells. Four locations within the Ebola virus Kikwit genome were identified that together segregate cell culture-passaged virus and virus obtained from infected non-human primates. Three of the identified sites are located within the glycoprotein gene (GP) sequence: the poly-U (RNA editing) site at position 6925, as well as positions 6677, and 6179. One site was found in the VP24 gene at position 10833. In all cases, in vitro and in vivo, both populations (majority and minority variants) were maintained in the viral swarm, with rapid selections occurring after a few passages or infections. This analysis approach will be useful to differentiate whether filovirus stocks with unknown history have been passaged in cell culture and may support filovirus stock standardization for medical countermeasure development.
Document Details
- Document Type
- Technical Report
- Publication Date
- Nov 28, 2012
- Accession Number
- ADA570691
Entities
People
- Anna N. Honko
- Chris A. Whitehouse
- Cynthia A. Rossi
- Gustavo Palacios
- Jeffrey R. Kugelman
- Jens H. Kuhn
- John M Dye
- Lisa Hensley
- Michael S. Lee
- Peter B. Jahrling
- Sarah E. Mccarthy
- Sheli R. Radoshitzky
- Sina Bavari
- Travis K. Warren
Organizations
- United States Army Medical Research Institute of Infectious Diseases